Cancer Research AACR Conference on Molecular Diagnostics - 2008  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 5307-5312, October 1, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kang, H.-i.
Right arrow Articles by Huh, N.-h.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kang, H.-i.
Right arrow Articles by Huh, N.-h.

Highly Sensitive, Specific Detection of O6-Methylguanine, O4-Methylthymine, and O4-Ethylthymine by the Combination of High-Performance Liquid Chromatography Prefractionation, 32P Postlabeling, and Immunoprecipitation1

Ho-il Kang, Chieko Konishi, Gertrud Eberle, Manfred F. Rajewsky, Toshio Kuroki and Nam-ho Huh2

Department of Cancer Cell Research, Institute of Medical Science, University of Tokyo, Shirokanedai, Minato-ku, Tokyo 108, Japan [H-i. K., C. K., T. K., N-h. H.], and Institute of Cell Biology (Cancer Research), University of Essen Medical School, D-4300 Essen 1, Germany [G. E., M. F. R.]

A highly sensitive and specific method for the detection of O6-methylguanine (O6-meG), O4-methylthymine (O4-meT), and O4-ethylthymine (O4-etT) has been established by combining prefractionation by high-performance liquid chromatography (HPLC), 32P postlabeling, and immunoprecipitation by monoclonal antibodies (PREPI method). DNA was enzymatically hydrolyzed to 2'-deoxynucleoside-3'-monophosphates (3'-dNps). Each alkyl 3'dNp was separated by reversephase HPLC, radiolabeled at the 5' position with [{gamma}-32P]ATP and polynucleotide kinase. After removing 3'-phosphate for better recognition by the antibodies, the resulting alkyl nucleotides were further fractionated by HPLC and finally precipitated specifically with respective antibodies. The detection limits were 1 fmol for all the alkyl nucleotides analyzed, so that one adduct in 108 of its normal counterpart nucleotide can be determined using ~100 µg (O4-meT and O4-etT) or ~150 µg (O6-meG) of DNA, i.e., 3–5 x 107 cells corresponding to ~10 ml of peripheral blood or a few hundred milligrams of tissue. By the use of the PREPI method, three leukocyte and three liver DNA samples from Japanese living in the Tokyo area were analyzed with respect to O-alkyl adduct content. O6-meG was detected in all three of the leukocyte samples (O6-meG:G molar ratio, 1.1 x, 0.8 x, and 1.6 x 10-8 as molar ratios to guanine). Neither O4-meT nor O4-etT was detected (detection limit, O4-alkylT:thymine molar ratio < 0.5 x 10-8). Among the liver samples analyzed, two cases showed positive O6-meG values (4.2 x and 1.1 x 10-7 O6-meG:guanine molar ratios). Contrary to the leukocyte DNA, O4-meT (3.9 x, 4.3 x, and 7.5 x 10-8 as O4-meT:thymine) and O4-etT (1.9 x, 4.9 x, and 8.7 x 10-8 as O4-etT:thymine) were detected in all the liver samples. These results indicate the validity of the PREPI method for molecular epidemiological studies on DNA alkylation products.

1 This work was supported in part by grants for Cancer Research and for Special Project Research, Cancer-Bioscience, from the Ministry of Education, Science and Culture of Japan and by the Deutsche Forschungsgemeinschaft (SFB 354/1).

2 To whom requests for reprints should be addressed, at Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108, Japan.

Received 4/14/92. Accepted 7/22/92.




This article has been cited by other articles:


Home page
Cancer Res.Home page
A. Tomita-Mitchell, L. L. Ling, C. L. Glover, J. Goodluck-Griffith, and W. G. Thilly
The Mutational Spectrum of the HPRT Gene from Human T Cells in Vivo Shares a Significant Concordant Set of Hot Spots with MNNG-treated Human Cells
Cancer Res., September 15, 2003; 63(18): 5793 - 5798.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
P. Georgiadis, E. Samoli, S. Kaila, K. Katsouyanni, and S. A. Kyrtopoulos
Ubiquitous Presence of O6-Methylguanine in Human Peripheral and Cord Blood DNA
Cancer Epidemiol. Biomarkers Prev., March 1, 2000; 9(3): 299 - 305.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.